Gout, Hyperuricemia, Uric Acid
Gout, Hyperuricemia, Uric Acid is a research topic within Nephrology. Science Explorer counts 18k research works in it since 1950. 17.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of uric acid in cardiovascular and renal health, focusing on its association with hyperuricemia, gout, hypertension, endothelial dysfunction, and metabolic syndrome. The papers also discuss the impact of xanthine oxidase inhibitors and the inflammatory pathways related to uric acid.
- Uric Acid
- Hyperuricemia
- Gout
- Cardiovascular Risk
- Renal Disease
- Hypertension
- Xanthine Oxidase Inhibitors
- Endothelial Dysfunction
- Metabolic Syndrome
- Inflammation
- Research works
- 18k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 17.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +33% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Gout, Hyperuricemia, Uric Acid research?
By volume, China and the United States publish the most (1.7k and 419 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.7k works
- 2 United States 419 works
- 3 India 179 works
- 4 Japan 161 works
- 5 South Korea 136 works
- 6 United Kingdom 93 works
- 7 Türkiye 89 works
- 8 Indonesia 77 works
- 9 Italy 77 works
- 10 France 73 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Gout, Hyperuricemia, Uric Acid research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Gout, Hyperuricemia, Uric Acid research, followed by Zhejiang Chinese Medical University and Guangzhou University of Chinese Medicine.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 28 works
- 2 Zhejiang Chinese Medical UniversityChina 22 works
- 3 Guangzhou University of Chinese MedicineChina 20 works
- 4 Qingdao UniversityChina 19 works
- 5 Beijing University of Chinese MedicineChina 18 works
- 6 Central South UniversityChina 18 works
- 7 Sichuan UniversityChina 18 works
- 8 Sun Yat-sen UniversityChina 17 works
- 9 Capital Medical UniversityChina 17 works
- 10 Peking UniversityChina 15 works
Who are the leading researchers in Gout, Hyperuricemia, Uric Acid?
The most-cited researchers publishing on Gout, Hyperuricemia, Uric Acid include Josef Coresh, Massimo Círillo and Jasvinder A. Singh.
- 1 Josef Coresh United States 5.3k citations
- 2 Massimo Círillo Italy 5.2k citations
- 3 Jasvinder A. Singh United States 4.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Gout, Hyperuricemia, Uric Acid research done?
The largest centres of Gout, Hyperuricemia, Uric Acid research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Hangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Wenzhou.
Largest cities, 2022–2025
Where it is the local speciality
- WenzhouCN · 20.2 works5.9×
Location quotient: how much more of its research is in Gout, Hyperuricemia, Uric Acid than the world average.
Where is the best place to study Gout, Hyperuricemia, Uric Acid?
Among universities, judged by research, China Medical University, Southern Medical University and Zhejiang Chinese Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | China Medical UniversityChina | 71.7 | 49.7% | 9.3× | 12 | +155.2% |
| 2 | Southern Medical UniversityChina | 70.4 | 32.2% | 10.1× | 14 | +482.9% |
| 3 | Zhejiang Chinese Medical UniversityChina | 65.4 | 28.9% | 22.3× | 22 | +75.7% |
| 4 | Anhui Medical UniversityChina | 64.6 | 39.8% | 12.1× | 14 | +62.7% |
| 5 | Beijing University of Chinese MedicineChina | 63.8 | 29.8% | 27.1× | 18 | +83.6% |
| 6 | Guangdong Pharmaceutical UniversityChina | 63.6 | 49.8% | 22.1× | 9 | — |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 62.3 | 21.3% | 7.5× | 28 | +108.8% |
| 8 | Guangzhou University of Chinese MedicineChina | 58.9 | 24.8% | 27.8× | 20 | +18.6% |
| 9 | Qingdao UniversityChina | 56.8 | 31.5% | 8.8× | 19 | -14.0% |
| 10 | China Pharmaceutical UniversityChina | 56.4 | 46.2% | 10.9× | 9 | -17.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Gout, Hyperuricemia, Uric Acid research growing?
Output in 2018–2022 was 33% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Gout, Hyperuricemia, Uric Acid.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.